Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods-Reference-Cited by-同舟云学术

Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods

Published:2019-07 Issue:7 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Oishi Tomohiro¹^ORCID,Takahashi Kento¹,Wakabayashi Shoko¹,Nakamura Yoshitaka¹,Ono Sahoko¹,Kono Mina¹,Kato Atsushi¹,Saito Aki¹,Kondo Eisuke¹,Tanaka Yuhei¹²,Teranishi Hideto¹,Akaike Hiroto¹,Tanaka Takaaki¹,Miyata Ippei¹^ORCID,Ogita Satoko¹,Ohno Naoki¹,Nakano Takashi¹,Ouchi Kazunobu¹

Affiliation:

1. Department of Pediatrics, Kawasaki Medical School, Okayama, Japan

2. Department of Pediatrics, Aso Iizuka Hospital, Fukuoka, Japan

Abstract

We compared the antimicrobial susceptibility of Mycoplasma pneumoniae isolates from pediatric patients in Japan in 2011–2012 and 2015–2016, when epidemics occurred. The antimicrobial activity of macrolides and tetracyclines against M. pneumoniae infection tended to be restored in 2015–2016.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02517-18

Reference17 articles.

1. National Institute of Infectious Diseases. 1998. Weekly cases of pneumonia caused by M. pneumoniae in Japan from April 1999 to present. (Graphs based on data of the National Epidemiological Surveillance of Infectious Diseases [NESID].) https://www.niid.go.jp/niid/en/10/2096-weeklygraph/1659-18myco.html.

2. Joint Committee of Japanese Society of Pediatric Infectious Disease and Japanese Society of Pediatric Pulmonology. 2017. Pneumonia, p 60. In Ouchi K, Kurosaki T, Okada K (ed), Guidelines for management of respiratory infectious diseases in children in Japan 2017. Kyowa Kikaku Ltd., Tokyo, Japan. (In Japanese.)

3. Characteristics of Macrolide-ResistantMycoplasma pneumoniaeStrains Isolated from Patients and Induced with ErythromycinIn Vitro

4. Large epidemic of mycoplasmal pneumonia caused by Mycoplasma pneumoniae strains highly resistant to macrolides among children in 2011;Ubukata K;IASR,2011

5. Nationwide Surveillance of Macrolide-Resistant Mycoplasma pneumoniae Infection in Pediatric Patients

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?;Revista Española de Quimioterapia;2023-03-27

2. Human health impacts;Fundamentals of Bioaerosols Science;2023

3. Meta-analysis of Macrolide Resistance Pattern of Mycoplasma pneumoniae in the World;2022-09-15

4. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020;Emerging Microbes & Infections;2022-06-02

5. Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae;Journal of Clinical Medicine;2022-03-24